Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Meningioma × GSK2256098 × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

abemaciclib 2 lutetium Lu 177 dotatate 1 gallium Ga 68 dotatate 1 capivasertib 1 cabozantinib 1 Specimen Handling 1 Radiosurgery 1 Nivolumab 1 Neuroimaging 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 HhAntag691 1 HES 130-0.4 1 GSK2256098 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02523014 2026-03-04

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Alliance for Clinical Trials in Oncology

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡